IRVING, Texas, May 20, 2021 /PRNewswire/ -- Darling Ingredients
Inc. (NYSE: DAR) today announced that its Rousselot brand, the
global leader of collagen-based solutions, expands its range of
purified, pharmaceutical grade, modified gelatins with the launch
of X-Pure® GelDAT – Gelatin Desaminotyrosine. Created in response
to customer's demand to overcome the barriers encountered in
clinical translation, this is the first, readily available
biomaterial of its kind. X-Pure® GelDAT offers guaranteed purity
and consistency at scale, vital to the successful development of
biomedical applications used in the human body.
X-Pure® GelDAT - A powerful alternative to
GelTYR
Until now, one of the go-to products for researchers
requiring a biomaterial more adhesive than GelMA - Gelatin
Methacryloyl, was GelTYR - Gelatin Tyramine. However, GelTYR has
several limitations, most notably its irreproducibility and the
lack of a scalable production process. The chemical reactions
required to make GelTYR lead to uncontrollable side reactions,
which can significantly delay product development and negatively
impact the likelihood of success.
Dr. Jeff Daelman, Business
Development Manager at Rousselot Biomedical said, "Based on our
extensive experience and scientific expertise in modified gelatins,
we created a versatile, effective and scalable alternative to
GelTYR. Rousselot® Biomedical delivered a tailored X-Pure® GelDAT
solution, from customer's initial briefing into pre-clinical trials
in less than a year!"
Customization and consistency
Rousselot's
proprietary, scalable process means products with customized
functionalities can be produced in a standardized, purified,
traceable and consistent manner. Rousselot offers the best of both
worlds: a customized yet consistent product on which both
researchers and large pharmaceutical manufacturers can
rely.
"Rousselot's X-Pure® GelDAT's research grade is functionally
equivalent to the GMP grade material, so researchers have less risk
of having to re-validate their biomaterial prior to clinical
trials. Compromising on quality in early research can also cause
significant scale-up issues and delays in preparation for clinical
trials. X-Pure® GelDAT can be used throughout every development
phase," said Dr. Daelman.
Unique adhesive properties for a range of specific biomedical
applications
New X-Pure GelDAT is a unique addition to the
Rousselot portfolio because of its phenolic modification that
grants superior adhesion properties to human tissues and because it
can be cross-linked by both enzymatic reaction or photo-induction.
These characteristics allow its combination with other biomaterials
for the creation of more versatile and complex structures for drug
delivery, tissue engineering, organ-on-a-chip and complex wound
dressing applications
Dr. Daelman concluded, "This is an exciting time for the
biomedical sector as highly purified and reliable gelatin-based
materials unlock the potential for new innovations. We are excited
to collaborate with customers and to jointly develop new
gelatin-based solutions, that have a positive impact in these
promising fields of research. We will be sharing more insights and
information during this year's BIO Digital 2021."
About Rousselot Biomedical
To learn more about
X-Pure®, and for partnership enquiries, please contact the
Rousselot Biomedical team here.
As the most recent strategic segment within Rousselot, a world
leading manufacturer of collagen-based solutions, we have drawn
upon 130 years of worldwide expertise and proven track record of
pharmaceutical gelatins and collagens to develop X-Pure®, an
innovative range of purified (modified) gelatins and collagens.
Offering unique advantages to assure performance, quality and
safety, X-Pure is backed by strong scientific data and on-going
research. Rousselot Biomedical is committed to engineer, accelerate
and scale superior products helping transform ideas into biomedical
solutions around the world using our scientific expertise
and collaborative approach to support end-to-end partnerships
and to advance medical science. For more information please
visit: www.rousselot.com/biomedical
About Darling
Darling Ingredients Inc. (NYSE: DAR) is
a world leading producer of organic ingredients, generating a wide
array of sustainable protein and fat products while being one of
the largest producers of renewable clean energy. With operations on
five continents, Darling collects waste streams from the agri-food
industry, repurposing into specialty ingredients, such as
hydrolyzed collagen, edible and feed-grade fats, animal proteins
and meals, plasma, pet food ingredients, fuel feedstocks, and green
bioenergy. Darling Ingredients named one of the 50 Sustainability
and Climate Leaders in 2021, to learn more Darling Ingredients: The
greenest Company on the planet - 50 Sustainability & Climate
Leaders (50climateleaders.com). The Company sells its ingredients
around the globe and works to strengthen our promise for a better
tomorrow, creating product applications for health, nutrients and
bioenergy while optimizing our services to the food chain. Darling
is a 50% joint venture partner in Diamond
Green Diesel (DGD), North
America's largest renewable diesel manufacturer, currently
producing approximately 290 million gallons of renewable diesel
annually which products reduce Greenhouse Gas (GHG) emissions by up
to 85% compared to fossil fuels. For additional information, visit
the Company's website at http://www.darlingii.com.
For more information, contact:
Rousselot
Biomedical
Catarina Da Silva
Science Communication Manager
[e] catarina.silva@rousselot.com
Sciad Communications
Emma
Pickup
[e] emma@sciad.com
Investor Relations
Jim
Stark
VP, Investor Relations
[e] james.stark@darlingii.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/darling-ingredients-rousselot-brand-launches-geldat-first-ever-purified-and-phenol-functionalized-gelatin-301296305.html
SOURCE Darling Ingredients Inc.